earnings
SV
NASDAQ · SVRA
Savara Inc.
Healthcare · Biotechnology
$4.78
Down-$0.13 (-2.72%)
Updated Oct 7, 2026, 1:04 AM
SID Score
3.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.41B
- P/E ratio
- -13.6
- Dividend yield
- 0.00%
- 52-week range
- $4.70 – $6.48
- Volume
- 2.86M
- Avg. volume
- 1.96M
Price performance · SVRA
SVRA price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 5, 2026
SVRA closed at $4.78 after 20 trading sessions, down 13.56% for the selected period.
- Last close
- $4.78
- Period change
- -13.56%
- Period low
- $4.78
- Period high
- $5.53
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 5, 2026 | $4.85 | $4.915 | $4.71 | $4.78 | 2.86M |
| Oct 2, 2026 | $5.10 | $5.16 | $4.765 | $4.81 | 2.65M |
| Oct 1, 2026 | $5.15 | $5.24 | $5.03 | $5.045 | 2.55M |
| Sep 30, 2026 | $5.15 | $5.24 | $5.05 | $5.16 | 6.05M |
| Sep 29, 2026 | $5.07 | $5.19 | $5.00 | $5.08 | 2.03M |
| Sep 28, 2026 | $4.97 | $5.155 | $4.86 | $5.07 | 4.37M |
| Sep 25, 2026 | $5.08 | $5.18 | $4.87 | $5.00 | 2.45M |
| Sep 24, 2026 | $5.03 | $5.085 | $4.884 | $5.07 | 2.5M |
| Sep 23, 2026 | $5.30 | $5.34 | $4.90 | $5.00 | 3.35M |
| Sep 22, 2026 | $5.52 | $5.525 | $5.29 | $5.30 | 1.41M |
| Sep 21, 2026 | $5.44 | $5.51 | $5.36 | $5.45 | 1.31M |
| Sep 18, 2026 | $5.42 | $5.47 | $5.305 | $5.37 | 2.18M |
| Sep 17, 2026 | $5.23 | $5.465 | $5.22 | $5.42 | 1.23M |
| Sep 16, 2026 | $5.29 | $5.3514 | $5.105 | $5.13 | 1.13M |
| Sep 15, 2026 | $5.33 | $5.34 | $5.175 | $5.26 | 1.3M |
| Sep 14, 2026 | $5.33 | $5.43 | $5.28 | $5.34 | 1.31M |
| Sep 11, 2026 | $5.38 | $5.395 | $5.27 | $5.30 | 1.06M |
| Sep 10, 2026 | $5.34 | $5.46 | $5.24 | $5.32 | 1.53M |
| Sep 9, 2026 | $5.48 | $5.57 | $5.37 | $5.415 | 1.1M |
| Sep 8, 2026 | $5.27 | $5.63 | $5.26 | $5.53 | 1.66M |
Latest SVRA news
The latest Smart Investors Daily articles mentioning SVRA.
Stock researchMarket Activity · Short Interest
Company
Market Activity
Research & News
Loading stock research…